EU approves AbbVie's Boey for short-duration frown line treatment
Go back to EU approves AbbVie's Boey for short-duration frown line treatment| AbbVie (NYSE: ABBV) | Delayed: 258.81 +1.89 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $256.92 | 52 Week High | $68.12 | |||
| Open | $258.54 | 52 Week Low | $50.71 | |||
| Day High | $260.22 | P/E | 56.14 | |||
| Day Low | $256.77 | EPS | $4.61 | |||
| Volume | 2,353,669 | |||||
